955 related articles for article (PubMed ID: 12370273)
1. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
Xiao H; Heeringa P; Hu P; Liu Z; Zhao M; Aratani Y; Maeda N; Falk RJ; Jennette JC
J Clin Invest; 2002 Oct; 110(7):955-63. PubMed ID: 12370273
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
3. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
5. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
Huugen D; Xiao H; van Esch A; Falk RJ; Peutz-Kootstra CJ; Buurman WA; Tervaert JW; Jennette JC; Heeringa P
Am J Pathol; 2005 Jul; 167(1):47-58. PubMed ID: 15972951
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
7. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
Xiao H; Heeringa P; Liu Z; Huugen D; Hu P; Maeda N; Falk RJ; Jennette JC
Am J Pathol; 2005 Jul; 167(1):39-45. PubMed ID: 15972950
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
9. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Gan PY; Holdsworth SR; Kitching AR; Ooi JD
Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
[TBL] [Abstract][Full Text] [Related]
11. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
Ooi JD; Chang J; Hickey MJ; Borza DB; Fugger L; Holdsworth SR; Kitching AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2615-24. PubMed ID: 22955884
[TBL] [Abstract][Full Text] [Related]
12. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis and classification of microscopic polyangiitis.
Kallenberg CG
J Autoimmun; 2014; 48-49():90-3. PubMed ID: 24461388
[TBL] [Abstract][Full Text] [Related]
14. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
Franssen CF; Stegeman CA; Kallenberg CG; Gans RO; De Jong PE; Hoorntje SJ; Tervaert JW
Kidney Int; 2000 Jun; 57(6):2195-206. PubMed ID: 10844589
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
16. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.
Bontscho J; Schreiber A; Manz RA; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2011 Feb; 22(2):336-48. PubMed ID: 21233415
[TBL] [Abstract][Full Text] [Related]
18. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
20. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]